Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2022 Filed Dec 19, 2022 21:05 UTC |
Musser Jeffrey SDirector · President and CEO
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 87.044 | $109.32 | $9,515.65 |
DisclosureSEC source: 0001127602-22-027819 · form4.xml · derivative · entry 5 Musser Jeffrey S · CIK 0001323312 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183.532 Underlying: Common Stock · 87.044 shares Expires not disclosed F4 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F4 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F4 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:05 UTC |
Musser Jeffrey SDirector · President and CEO
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 52.826 | $109.32 Strike: $0.00 | $5,774.94 |
DisclosureSEC source: 0001127602-22-027819 · form4.xml · derivative · entry 4 Musser Jeffrey S · CIK 0001323312 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188.084 Underlying: Common Stock · 52.826 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:05 UTC |
Musser Jeffrey SDirector · President and CEO
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 34.693 | $109.32 | $3,792.64 |
DisclosureSEC source: 0001127602-22-027819 · form4.xml · derivative · entry 3 Musser Jeffrey S · CIK 0001323312 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194.279 Underlying: Common Stock · 34.693 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:47 UTC |
Dickerman Jeffrey FSenior VP/Gen Counsel/Corp Sec
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 15.643 | $109.32 | $1,710.09 |
DisclosureSEC source: 0001127602-22-027804 · form4.xml · derivative · entry 4 Dickerman Jeffrey F · CIK 0001797778 · Senior VP/Gen Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32.983 Underlying: Common Stock · 15.643 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:47 UTC |
Dickerman Jeffrey FSenior VP/Gen Counsel/Corp Sec
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 9.468 | $109.32 Strike: $0.00 | $1,035.04 |
DisclosureSEC source: 0001127602-22-027804 · form4.xml · derivative · entry 3 Dickerman Jeffrey F · CIK 0001797778 · Senior VP/Gen Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34.334 Underlying: Common Stock · 9.468 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:47 UTC |
Dickerman Jeffrey FSenior VP/Gen Counsel/Corp Sec
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 6.219 | $109.32 | $679.86 |
DisclosureSEC source: 0001127602-22-027804 · form4.xml · derivative · entry 2 Dickerman Jeffrey F · CIK 0001797778 · Senior VP/Gen Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34.884 Underlying: Common Stock · 6.219 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:39 UTC |
Clark Benjamin G.SVP - Chief Strategy Officer
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 15.643 | $109.32 | $1,710.09 |
DisclosureSEC source: 0001127602-22-027802 · form4.xml · derivative · entry 4 Clark Benjamin G. · CIK 0001634903 · SVP - Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32.983 Underlying: Common Stock · 15.643 shares Expires not disclosed F4 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F4 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F4 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:39 UTC |
Clark Benjamin G.SVP - Chief Strategy Officer
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 9.468 | $109.32 Strike: $0.00 | $1,035.04 |
DisclosureSEC source: 0001127602-22-027802 · form4.xml · derivative · entry 3 Clark Benjamin G. · CIK 0001634903 · SVP - Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34.334 Underlying: Common Stock · 9.468 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:39 UTC |
Clark Benjamin G.SVP - Chief Strategy Officer
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 6.219 | $109.32 | $679.86 |
DisclosureSEC source: 0001127602-22-027802 · form4.xml · derivative · entry 2 Clark Benjamin G. · CIK 0001634903 · SVP - Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34.884 Underlying: Common Stock · 6.219 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:57 UTC |
McClincy Christopher J.Senior VP - CIO
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 15.643 | $109.32 | $1,710.09 |
DisclosureSEC source: 0001127602-22-027809 · form4.xml · derivative · entry 4 McClincy Christopher J. · CIK 0001627405 · Senior VP - CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32.983 Underlying: Common Stock · 15.643 shares Expires not disclosed F4 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F4 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F4 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:57 UTC |
McClincy Christopher J.Senior VP - CIO
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 9.468 | $109.32 Strike: $0.00 | $1,035.04 |
DisclosureSEC source: 0001127602-22-027809 · form4.xml · derivative · entry 3 McClincy Christopher J. · CIK 0001627405 · Senior VP - CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34.334 Underlying: Common Stock · 9.468 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:57 UTC |
McClincy Christopher J.Senior VP - CIO
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 6.219 | $109.32 | $679.86 |
DisclosureSEC source: 0001127602-22-027809 · form4.xml · derivative · entry 2 McClincy Christopher J. · CIK 0001627405 · Senior VP - CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34.884 Underlying: Common Stock · 6.219 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 19:58 UTC |
ALGER EUGENE KPresident Global Services
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 35.155 | $109.32 | $3,843.14 |
DisclosureSEC source: 0001127602-22-027796 · form4.xml · derivative · entry 4 ALGER EUGENE K · CIK 0001232713 · President Global Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74.124 Underlying: Common Stock · 35.155 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 19:58 UTC |
ALGER EUGENE KPresident Global Services
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 21.344 | $109.32 | $2,333.33 |
DisclosureSEC source: 0001127602-22-027796 · form4.xml · derivative · entry 3 ALGER EUGENE K · CIK 0001232713 · President Global Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75.946 Underlying: Common Stock · 21.344 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 19:58 UTC |
ALGER EUGENE KPresident Global Services
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 14.018 | $109.32 | $1,532.45 |
DisclosureSEC source: 0001127602-22-027796 · form4.xml · derivative · entry 2 ALGER EUGENE K · CIK 0001232713 · President Global Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78.29 Underlying: Common Stock · 14.018 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 18:35 UTC |
Rostan Richard HPresident - Global Geographies
|
GiftCommon Stock | 375 | $107.91 | $40,466.25 |
DisclosureSEC source: 0001127602-22-027381 · form4.xml · nonDerivative · entry 1 Rostan Richard H · CIK 0001698713 · President - Global Geographies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,109.2711 F1 · kind: Shares were gifted to various family members who do not share reporting person's household. F2 · balance_after: Balance of Common Stock beneficially owned includes 197.4878 shares purchased on July 29, 2022 under Expeditors International of Washington, Inc.'s 2002 Employee Stock Purchase Plan. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 22:37 UTC |
ALGER EUGENE KPresident Global Services
|
SaleCommon Stock | 11,500 | $113.43 | $1,304,422.00 |
DisclosureSEC source: 0001127602-22-025983 · form4.xml · nonDerivative · entry 1 ALGER EUGENE K · CIK 0001232713 · President Global Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,878.6429 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.33 to $113.46, inclusive. The reporting person undertakes to provide to any security holder of Expeditors or to the SEC, upon request, full information regarding the number of shares sold at each separate price within the range stated. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 19:02 UTC |
POWELL BRADLEY SSenior VP - CFO
|
SaleCommon Stock | 200 | $107.80 | $21,559.00 |
DisclosureSEC source: 0001127602-22-025421 · form4.xml · nonDerivative · entry 4 POWELL BRADLEY S · CIK 0001201470 · Senior VP - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.78 to $107.81, inclusive. The reporting person undertakes to provide to any security holder of Expeditors or to the SEC, upon request, full information regarding the number of shares sold at each separate price within the range stated. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 19:02 UTC |
POWELL BRADLEY SSenior VP - CFO
|
SaleCommon Stock | 6,966 | $107.26 | $747,145.30 |
DisclosureSEC source: 0001127602-22-025421 · form4.xml · nonDerivative · entry 3 POWELL BRADLEY S · CIK 0001201470 · Senior VP - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.78 to $107.75, inclusive. The reporting person undertakes to provide to any security holder of Expeditors or to the SEC, upon request, full information regarding the number of shares sold at each separate price within the range stated. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 19:02 UTC |
POWELL BRADLEY SSenior VP - CFO
|
SaleCommon Stock | 3,282 | $106.32 | $348,938.96 |
DisclosureSEC source: 0001127602-22-025421 · form4.xml · nonDerivative · entry 2 POWELL BRADLEY S · CIK 0001201470 · Senior VP - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,166 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.71 to $106.70, inclusive. The reporting person undertakes to provide to any security holder of Expeditors or to the SEC, upon request, full information regarding the number of shares sold at each separate price within the range stated. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 19:02 UTC |
POWELL BRADLEY SSenior VP - CFO
|
SaleCommon Stock | 6,757.9667 | $105.09 | $710,194.72 |
DisclosureSEC source: 0001127602-22-025421 · form4.xml · nonDerivative · entry 1 POWELL BRADLEY S · CIK 0001201470 · Senior VP - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,448 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.66 to $105.65, inclusive. The reporting person undertakes to provide to any security holder of Expeditors or to the SEC, upon request, full information regarding the number of shares sold at each separate price within the range stated. F2 · balance_after: Balance of Common Stock beneficially owned includes 197.4878 shares purchased on July 29, 2022 under Expeditors International of Washington, Inc.'s 2002 Employee Stock Purchase Plan. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 18:47 UTC |
Dickerman Jeffrey FSenior VP/Gen Counsel/Corp Sec
|
SaleCommon Stock | 986 | $106.60 | $105,102.67 |
DisclosureSEC source: 0001127602-22-025415 · form4.xml · nonDerivative · entry 1 Dickerman Jeffrey F · CIK 0001797778 · Senior VP/Gen Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,769.7304 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.56 to $106.60, inclusive. The reporting person undertakes to provide to any security holder of Expeditors or to the SEC, upon request, full information regarding the number of shares sold at each separate price within the range stated. F2 · balance_after: Balance of Common Stock beneficially owned includes 197.4878 shares purchased on July 29, 2022 under Expeditors International of Washington, Inc.'s 2002 Employee Stock Purchase Plan. Read SEC document |
| August 10, 2022 Filed Aug 17, 2022 19:00 UTC |
ALGER EUGENE KPresident Global Services
|
SaleCommon Stock | 2,981 | $107.29 | $319,821.65 |
DisclosureSEC source: 0001127602-22-021165 · form4.xml · nonDerivative · entry 2 ALGER EUGENE K · CIK 0001232713 · President Global Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,378.6429 F1 · balance_after: Balance of Common Stock beneficially owned includes 197.4878 shares purchased on July 29, 2022 under Expeditors International of Washington, Inc.'s 2002 Employee Stock Purchase Plan. Read SEC document |
| August 10, 2022 Filed Aug 17, 2022 19:00 UTC |
ALGER EUGENE KPresident Global Services
|
SaleCommon Stock | 7,157 | $107.35 | $768,301.80 |
DisclosureSEC source: 0001127602-22-021165 · form4.xml · nonDerivative · entry 1 ALGER EUGENE K · CIK 0001232713 · President Global Services 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 0 Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 17:14 UTC |
Gulyas Diane H.Director
|
GiftCommon Stock | 2,000 | $103.10 | $206,200.00 |
DisclosureSEC source: 0001127602-22-020753 · form4.xml · nonDerivative · entry 1 Gulyas Diane H. · CIK 0001466674 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 17,846 F1 · shares: The transaction reported involved a gift by the reporting person of 2,000 shares of common stock to a charitable fund. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:37 UTC |
Rostan Richard HPresident - Global Geographies
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 34.516 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017740 · form4.xml · derivative · entry 4 Rostan Richard H · CIK 0001698713 · President - Global Geographies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34.516 Underlying: Common Stock · 34.516 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:37 UTC |
Rostan Richard HPresident - Global Geographies
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 20.942 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017740 · form4.xml · derivative · entry 3 Rostan Richard H · CIK 0001698713 · President - Global Geographies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48.603 Underlying: Common Stock · 20.942 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:37 UTC |
Rostan Richard HPresident - Global Geographies
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 13.758 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017740 · form4.xml · derivative · entry 2 Rostan Richard H · CIK 0001698713 · President - Global Geographies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57.066 Underlying: Common Stock · 13.758 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:50 UTC |
Wall Daniel RPresident, Global Products
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 38.969 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017742 · form4.xml · derivative · entry 4 Wall Daniel R · CIK 0001303014 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38.969 Underlying: Common Stock · 38.969 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:50 UTC |
Wall Daniel RPresident, Global Products
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 23.66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017742 · form4.xml · derivative · entry 3 Wall Daniel R · CIK 0001303014 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54.602 Underlying: Common Stock · 23.66 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:50 UTC |
Wall Daniel RPresident, Global Products
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 15.539 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017742 · form4.xml · derivative · entry 2 Wall Daniel R · CIK 0001303014 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64.272 Underlying: Common Stock · 15.539 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:25 UTC |
POWELL BRADLEY SSenior VP - CFO
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 38.969 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017738 · form4.xml · derivative · entry 4 POWELL BRADLEY S · CIK 0001201470 · Senior VP - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38.969 Underlying: Common Stock · 38.969 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:25 UTC |
POWELL BRADLEY SSenior VP - CFO
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 23.66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017738 · form4.xml · derivative · entry 3 POWELL BRADLEY S · CIK 0001201470 · Senior VP - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54.602 Underlying: Common Stock · 23.66 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:25 UTC |
POWELL BRADLEY SSenior VP - CFO
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 15.539 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017738 · form4.xml · derivative · entry 2 POWELL BRADLEY S · CIK 0001201470 · Senior VP - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64.272 Underlying: Common Stock · 15.539 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:59 UTC |
Musser Jeffrey SDirector · President and CEO
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 96.488 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017734 · form4.xml · derivative · entry 5 Musser Jeffrey S · CIK 0001323312 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96.488 Underlying: Common Stock · 96.488 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:59 UTC |
Musser Jeffrey SDirector · President and CEO
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 58.557 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017734 · form4.xml · derivative · entry 4 Musser Jeffrey S · CIK 0001323312 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135.258 Underlying: Common Stock · 58.557 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:59 UTC |
Musser Jeffrey SDirector · President and CEO
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 38.457 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017734 · form4.xml · derivative · entry 3 Musser Jeffrey S · CIK 0001323312 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159.586 Underlying: Common Stock · 38.457 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:56 UTC |
McClincy Christopher J.Senior VP - CIO
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 17.34 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017732 · form4.xml · derivative · entry 4 McClincy Christopher J. · CIK 0001627405 · Senior VP - CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17.34 Underlying: Common Stock · 17.34 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:56 UTC |
McClincy Christopher J.Senior VP - CIO
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 10.495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017732 · form4.xml · derivative · entry 3 McClincy Christopher J. · CIK 0001627405 · Senior VP - CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24.866 Underlying: Common Stock · 10.495 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:56 UTC |
McClincy Christopher J.Senior VP - CIO
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 6.893 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017732 · form4.xml · derivative · entry 2 McClincy Christopher J. · CIK 0001627405 · Senior VP - CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28.665 Underlying: Common Stock · 6.893 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:53 UTC |
Dickerman Jeffrey FSenior VP/Gen Counsel/Corp Sec
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 17.34 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017728 · form4.xml · derivative · entry 4 Dickerman Jeffrey F · CIK 0001797778 · Senior VP/Gen Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17.34 Underlying: Common Stock · 17.34 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:53 UTC |
Dickerman Jeffrey FSenior VP/Gen Counsel/Corp Sec
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 10.495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017728 · form4.xml · derivative · entry 3 Dickerman Jeffrey F · CIK 0001797778 · Senior VP/Gen Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24.866 Underlying: Common Stock · 10.495 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:53 UTC |
Dickerman Jeffrey FSenior VP/Gen Counsel/Corp Sec
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 6.893 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017728 · form4.xml · derivative · entry 2 Dickerman Jeffrey F · CIK 0001797778 · Senior VP/Gen Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28.665 Underlying: Common Stock · 6.893 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:50 UTC |
Clark Benjamin G.SVP - Chief Strategy Officer
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 17.34 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017725 · form4.xml · derivative · entry 4 Clark Benjamin G. · CIK 0001634903 · SVP - Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17.34 Underlying: Common Stock · 17.34 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:50 UTC |
Clark Benjamin G.SVP - Chief Strategy Officer
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 10.495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017725 · form4.xml · derivative · entry 3 Clark Benjamin G. · CIK 0001634903 · SVP - Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24.866 Underlying: Common Stock · 10.495 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:50 UTC |
Clark Benjamin G.SVP - Chief Strategy Officer
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 6.893 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017725 · form4.xml · derivative · entry 2 Clark Benjamin G. · CIK 0001634903 · SVP - Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28.665 Underlying: Common Stock · 6.893 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:47 UTC |
ALGER EUGENE KPresident Global Services
|
GrantDividend Equivalent Rights - 2022 RSUs · Derivative | 38.969 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017722 · form4.xml · derivative · entry 5 ALGER EUGENE K · CIK 0001232713 · President Global Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38.969 Underlying: Common Stock · 38.969 shares Expires not disclosed F3 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2022 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:47 UTC |
ALGER EUGENE KPresident Global Services
|
GrantDividend Equivalent Rights - 2021 RSUs · Derivative | 23.66 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017722 · form4.xml · derivative · entry 4 ALGER EUGENE K · CIK 0001232713 · President Global Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54.602 Underlying: Common Stock · 23.66 shares Expires not disclosed F2 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2021 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:47 UTC |
ALGER EUGENE KPresident Global Services
|
GrantDividend Equivalent Rights - 2020 RSUs · Derivative | 15.539 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017722 · form4.xml · derivative · entry 3 ALGER EUGENE K · CIK 0001232713 · President Global Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64.272 Underlying: Common Stock · 15.539 shares Expires not disclosed F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.exercise_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. F1 · derivative.expiration_date: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2020 grant of restricted stock units, and become exercisable proportionately with the restricted stock units to which they relate. Read SEC document |
| May 06, 2022 Filed May 10, 2022 17:18 UTC |
Wall Daniel RPresident, Global Products
|
Exercise / conversionDividend Equivalent Rights - 2019 RSUs · Derivative | 79.799 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013930 · form4.xml · derivative · entry 6 Wall Daniel R · CIK 0001303014 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 79.799 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU and DER represent a contingent right to receive the economic equivalent of one common shares of the issuer. The RSUs and DERs vested on May 7, 2022. F1 · derivative.exercise_date: Each RSU and DER represent a contingent right to receive the economic equivalent of one common shares of the issuer. The RSUs and DERs vested on May 7, 2022. F1 · derivative.expiration_date: Each RSU and DER represent a contingent right to receive the economic equivalent of one common shares of the issuer. The RSUs and DERs vested on May 7, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.